Join
Live feed
·
INSIDERFilingvia Quantisnow
Fennec Pharmaceuticals Inc. logo

Chief Executive Officer Hackman Jeffrey S. converted options into 13,710 shares, increasing direct ownership by 91% to 28,710 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FENC· Fennec Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FENC (Fennec Pharmaceuticals Inc.) and more on Quantisnow.

Chief Executive Officer Hackman Jeffrey S. converted options into 13,710 shares, increasing direct ownership by 91% to 28,710 units (SEC Form 4) | Quantisnow